Screener
Dyne Therapeutics, Inc. DYN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
FAQ
- What is Dyne Therapeutics, Inc.'s current ratio?
- Dyne Therapeutics, Inc. (DYN) reported current ratio of 19.9× in Q1 2026.
- How has Dyne Therapeutics, Inc.'s current ratio changed year-over-year?
- Dyne Therapeutics, Inc.'s current ratio decreased by 2.1% year-over-year, from 20.4× to 19.9×.
- What is the long-term trend for Dyne Therapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s current ratio has grown at a -6.9% compound annual growth rate (CAGR), from 31.8× to 22.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Dyne Therapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude